Up First briefing: Trump won't testify; FDA approves landmark gene-editing treatment
![Former President Donald Trump sits in the courtroom with his attorneys Joe Tacopina and Boris Epshteyn (right) during his arraignment at the Manhattan Criminal Court on April 4 in New York City.](https://media.npr.org/assets/img/2023/12/11/gettyimages-1479828982_wide-5a74e8bb8a3f432fb7000d179678d7a931eb23f8.jpg?s=600)
Donald Trump plans to skip testifying for a second time in the New York civil fraud trial. The FDA has approved the first-ever gene-editing treatment for a human disease.
(Image credit: Pool/Getty Images)
![](https://media.npr.org/include/images/tracking/npr-rss-pixel.png?story=1218495356)